Skip to main content
Editorial
Hope Springs Eternal: A New Year of HOPA Annual Conference Research Abstracts
Courtney C. Cavalieri, PharmD, BCOP; Michael Williams, PharmD, BCOP
Read More
HOPA Abstracts
Evaluation of a Biosimilar Conversion in an Academic Medical Center Outpatient Infusion Center
Abstract #CR01
Sidney Keisner, PharmD, BCOP
Read More
HOPA Abstracts
Outcomes of Supportive Care Versus Pharmacologic Intervention for the Management of CRS in Relapsed or Refractory Multiple Myeloma Treated With BCMA- and GPRC5D-Directed Bispecifics
Abstract #CR02
Victoria Nachar, PharmD, BCOP; James Davis, PharmD, BCOP
Read More
HOPA Abstracts
From Diagnosis to Decision-Making: Black Patient and Caregiver Perspectives on Lung Cancer Care and Support Needs
Abstract #CR03
Shanada Monestime, PharmD, BCOP
Read More
HOPA Abstracts
Safety of Live-Attenuated MMR Vaccination in Patients With Multiple Myeloma Receiving Daratumumab After Autologous Stem-Cell Transplantation
Abstract #CR04
James A. Davis, PharmD, BCOP
Read More
HOPA Abstracts
A Real-World Analysis of Filgrastim and Biosimilars for Engraftment After Hemopoietic Cell Transplantation: Balancing Efficacy and Economics
Abstract #CR05
Dennis Marjoncu, PharmD, BCOP; Kori Holman, PharmD, BCOP
Read More
HOPA Abstracts
Impact of an Oncolytic Pharmacist Prescription Verification Queue at an Academic Medical Center
Abstract #CR06
Kelsea Seago, PharmD, BCOP; Christine Barrett, PharmD, BCOP
Read More
HOPA Abstracts
Dexamethasone Versus Tocilizumab for Management of Talquetamab-Induced Cytokine Release Syndrome in Patients With Relapsed/Refractory Multiple Myeloma: A Multicenter, Retrospective Study
Abstract #CR07
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP
Read More
HOPA Abstracts
Phase 3 Study to Evaluate Efficacy and Safety of Pemivibart, an IgG1 Monoclonal Antibody, for the Prevention of COVID-19 (CANOPY): Subset Analysis of Participants With Chronic Lymphocytic Leukemia
Abstract #CR08
Kirthana Beaulac, PharmD
Read More
HOPA Abstracts
Safety of Shortened Postinfusion Observation Times for Pertuzumab and Ado-trastuzumab Emtansine: Retrospective and Prospective Analyses
Abstract #CR09
Jennifer Hutchinson, PharmD, BCOP
Read More
Page 2 of 197
Results 11 - 20 of 1963